Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
This study has been completed.
Ian F. Pollack, M.D.
Information provided by (Responsible Party):
Ian F. Pollack, M.D., University of Pittsburgh
First received: November 19, 2008
Last updated: July 4, 2017
Last verified: July 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||July 2015|
|Primary Completion Date:||February 2013 (Final data collection date for primary outcome measure)|